EP02.04-007 Phase 2 Trial of Neoadjuvant KRASG12C Directed Therapy with Adagrasib (MRTX849) With or Without Nivolumab in Resectable NSCLC (Neo-KAN)

S.C. Scott, C. Hu, K. Smith, V. Anagnostou, Joan Y. Lee, J. Spicer, P. Illei, E. Prophet, Samuel Rosner, D. Ettinger, J. Feliciano, C. Hann, V. Lam, B. Levy, J. Murray, J. Brahmer, P. Forde, Kristen A. Marrone